AVDNYSEAgricultural ChemicalsFiscal year ends December 31

AMERICAN VANGUARD CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Sep 30, 2026

$1.07+0.01 (+0.94%)

Close on Oct 19, 2026

Market cap: $30.65M
P/E (TTM): –
Dividend yield: –

AMERICAN VANGUARD CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	515	547	579	610	558	459	468	454	355	312	289	299	381	366	301	227	206
Cost of Revenue	368	427	400	417	387	286	291	272	208	184	177	184	210	205	178	141	149
Gross Profit	148	120	179	192	171	173	177	183	147	128	112	114	171	161	123	86	57
Research & Development	23	33	38	32	29	26	24	26	26	21	19	21	22	21	18	13	–
Selling, General & Admin	111	120	117	120	111	–	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	–	–	–	52	48	36	47	43	38	32	29	27	34	30	21	18	–
Advertising Expenses	2.70	4.11	5.74	5.84	5.20	4.83	5.52	4.87	3.02	2.27	3.54	4.32	4.01	2.68	2.10	2.53	–
Operating Expenses	8.89	11	12	11	183	154	151	144	121	108	100	108	116	102	84	67	63
Operating Income	-28	-102	23	41	31	23	26	39	27	21	12	6.71	56	59	39	19	-6.33
Interest Expense	18	17	13	3.95	3.69	5.18	7.21	4.02	1.94	1.62	2.56	3.07	2.18	2.87	3.57	3.17	3.25
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	0.02	0.00	0.00	0.00	–	–
Income from Equity Investments	–	–	0	0	-0.39	-0.13	-0.21	-0.39	-0.05	-0.35	-0.63	-0.98	-0.99	–	–	–	–
Asset Impairment Charges	25	50	0	0	0	0	0	0	0	0	0	5.36	0	0	–	–	–
Gain (Loss) on Sale of Assets	0.08	1.00	0	-0.27	-0.19	-0.12	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-47	-120	10	36	27	18	19	34	25	19	8.96	3.64	54	57	35	16	-9.54
Income Tax Expense	2.68	5.88	2.78	8.56	8.17	3.08	5.20	9.15	4.44	5.54	2.01	-0.45	19	20	13	5.19	-3.75
Net Income incl. Noncontrolling Interests	-50	-126	7.52	27	19	15	14	24	20	13	6.32	4.07	34	37	22	11	–
Minority Interest in Earnings	–	–	–	–	–	–	–	-0.13	0.09	0.24	-0.27	-0.78	-0.52	-0.04	–	–	–
Net Income	-50	-126	7.52	27	19	15	14	24	20	13	6.59	4.84	34	37	22	11	-5.79
EPS (Basic)(per share)	-1.75	-4.50	0.27	0.94	0.62	0.52	0.47	0.83	0.70	0.44	0.23	0.17	1.22	1.32	0.80	0.40	-0.21
EPS (Diluted)(per share)	-1.75	-4.50	0.26	0.92	0.61	0.51	0.46	0.81	0.68	0.44	0.23	0.17	1.19	1.28	0.79	0.40	-0.21
Shares Outstanding (Basic, Weighted)(shares)	28	28	28	29	30	29	29	29	29	29	29	28	28	28	28	27	27
Shares Outstanding (Diluted, Weighted)(shares)	28	28	29	30	30	30	30	30	30	29	29	29	29	29	28	28	27
Dividend per Share(per share)	–	0.06	0.12	0.10	0.08	0.04	0.08	0.08	0.06	0.03	0.02	0.17	0.22	0.22	0.08	0.03	0.06
EBITDA	-23	-96	30	50	40	43	45	58	44	37	28	23	71	73	53	30	4.48

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 29.4%
Operating margin: -5.2%
Net margin: -10.7%
Return on equity, FY2025: –

Financial strength

Current ratio: 2.47
Debt to equity: –
Debt to assets: 42.1%
Cash to current liabilities: 26.0%

Valuation

P/E ratio: –
Price to sales: 0.06
Price to book: –
Dividend yield: –